The board of directors of China Jiuhao Health Industry Corporation Limited announced that the shareholders of the company and potential investors that based on the information currently available to the Company and the preliminary assessment by the company's management with reference to the unaudited management accounts of the Group for the year ended 31 December 2014, the Group is expected to record a remarkable net profit for the year ended 31 December 2014 as compared with the audited loss for the year ended 31 December 2013. The Board considers that the expected improvement in the overall results of the Group for the year ended 31 December 2014 as compared with the year ended 31 December 2013 was principally due to the following reasons: There was no finance cost arising from the convertible note and promissory note of the Group for the year ended 31 December 2014 as compared to the relevant finance costs for the year ended 31 December 2013 of approximately HKD 54 million; Fair value gain on investment securities for the year ended 31 December 2014 amounted to approximately HKD 55 million, which increased significantly as compared to relevant gain for the year ended 31 December 2013 of approximately HKD 4 million; and there was a gain on disposal of discontinued operations of approximately HKD 11 million for the year ended 31 December 2014 as compared to a loss from discontinued operations of approximately HKD 65 million for the year ended 31 December 2013.